AVRA Company Updates

On February 14, 2017, AVRA filed a Registration on Form S-1 with the U.S. Securities and Exchange Commission covering the resale of certain of our outstanding shares of common stock with a view to becoming a fully reporting public company.

VIEW OUR REGISTRATION STATEMENT >


On July 31, 2017 the S1 was deemed effective by the SEC.

NOTICE OF EFFECTIVENESS>


On January 31, 2019 AVRA Medical Robotics’ CEO Mr. Barry Cohen released letter to update Shareholders

VIEW LETTER>


ORLANDO, FL – May 8, 2019 – AVRA Medical Robotics, Inc. (the “Company”) (OTCQB:AVMR), an emerging company that is creating the next generation of autonomous surgical robotics through the use of technologies such as artificial intelligence, machine learning and proprietary medical software architecture, announced today that it has retained The Horizon Phoenix Group and its principal Mr. Timothy K. Duggins as a regulatory consultant. The company entered into a four-year contract to conduct regulatory work on behalf of AVRA..

VIEW PRESS RELEASE >


For more Information regarding investor relations please call us at (1) 407 956 2250 – Extension 9 or email us via the contact form.

Investor Questions

VIEW OR DOWNLOAD OUR SEC FILINGS

To join our mailing list please submit your Name and Email below